Get an alert when VERYAN HOLDINGS LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Next accounts due

2026-09-30 (in 4mo)

Last filed for 2024-12-31

Confirmation statement due

2026-11-27 (in 6mo)

Last made up 2025-11-13

Watchouts

None on the register

Cash

£2M

-11.7% vs 2023

Net assets

£13M

+6.2% vs 2023

Employees

2

-33.3% vs 2023

Profit before tax

-£4M

+29.1% vs 2023

Name history

Renamed 1 time since incorporation

  1. VERYAN HOLDINGS LIMITED 2008-04-14 → present
  2. FLOORTENT LIMITED 2007-11-13 → 2008-04-14

Accounts

2-year trend · latest reflected 2024-12-31

Metric Trend 2023-12-312024-12-31
Turnover £11,695,652£11,719,948
Operating profit -£5,022,152-£3,009,969
Profit before tax -£5,168,964-£3,664,558
Net profit -£5,168,964-£3,450,198
Cash £2,019,385£1,783,134
Total assets less current liabilities £12,093,769£12,843,571
Net assets £12,093,769£12,843,571
Equity £12,093,769£12,843,571
Average employees 32
Wages £893,519£811,053

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2023-12-312024-12-31
Operating margin -42.9%-25.7%
Net margin -44.2%-29.4%
Return on capital employed -41.5%-23.4%
Gearing (liabilities / total assets) 3.3%2.9%
Current ratio 30.44x34.97x
Interest cover -16.34x-3.71x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Audit & accounting basis

Accounting basis
FRS 101
Reporting scope
Standalone (parent only)
Auditor
KPMG
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“After making enquiries and considering the support described above, the directors have a reasonable expectation that the company will have adequate resources to continue in operational existence for a period of not less than 12 months from the date of approval of the financial statements. Accordingly, the directors consider it appropriate for the financial statements to be prepared on a going concern basis.”

Group structure

  1. VERYAN HOLDINGS LIMITED · parent
    1. Veryan Medical Limited 100% · England · Development and commercial distribution of stents
    2. Veryan Medical Inc 100% · USA · Clinical trials management and commercial distribution of stents

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

6 active · 27 resigned

Name Role Appointed Born Nationality
PENNSEC LIMITED Corporate Secretary 2024-11-13
BELL, Christian Director 2018-12-12 Apr 1972 German
KOBAYASHI, Kazumichi Director 2019-09-25 Aug 1959 Japanese
O'CONNOR, Ronan Director 2020-04-01 Nov 1966 Irish
TAYLOR, Charles Richard Director 2008-01-10 Feb 1959 British
TOJO, Noriko Director 2021-11-25 Feb 1964 Japanese
Show 27 resigned officers
Name Role Appointed Resigned
DOHERTY, Frances Patricia Secretary 2008-01-10 2009-09-10
ALDWYCH SECRETARIES LIMITED Corporate Secretary 2019-04-09 2024-11-13
ALDWYCH SECRETARIES LIMITED Corporate Secretary 2009-09-10 2018-12-12
SWIFT INCORPORATIONS LIMITED Corporate Secretary 2007-11-13 2008-01-10
BIRCH, Philip Lloyd Director 2008-03-26 2009-07-31
BRISTER, David John Director 2010-12-23 2012-02-15
CARO, Colin, Professor Director 2008-03-26 2011-12-14
CARTMELL, Simon Christopher Director 2015-01-14 2018-12-12
CHESHIRE, Nicholas, Professor Director 2008-03-26 2010-03-09
CHRISTOU, Victor, Dr. Director 2008-03-26 2009-05-11
EDWARDS, Alan Director 2008-03-26 2010-03-09
EYERS, Rob Director 2018-12-12 2022-11-10
FUJITA, Tomoko Director 2009-06-09 2010-03-09
GILSON, Paul Director 2008-03-26 2017-03-31
HOLDEN, John Peter Stefano Director 2008-07-18 2012-11-09
JUMP, Jeff Director 2012-04-17 2018-03-20
O'CONNELL, Alan William, Dr Director 2010-03-09 2018-12-12
PITCHFORD, Nigel Aaron Director 2012-11-09 2018-10-03
POPE, Todd Mcneil Director 2012-04-17 2015-01-14
STEWART, Alastair John Director 2012-04-17 2013-12-17
TODD, Rebecca Thirza Director 2009-07-09 2010-12-23
TOTTY, James Thomas, Dr Director 2008-07-23 2009-06-08
VERNON, Geoffrey Nicholas, Dr Director 2008-07-23 2016-05-31
YEO, Nicholas Howard Grenville Director 2018-12-12 2022-08-01
YOSHIDA, Koji Director 2018-12-12 2019-09-25
INSTANT COMPANIES LIMITED Corporate Director 2007-11-13 2008-01-10
IP2IPO SERVICES LIMITED Corporate Director 2018-10-15 2018-12-12

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Otsuka Medical Devices Uk Limited Corporate entity Shares 75–100%, Voting 75–100% 2018-12-12 Active
Imperial Innovations Businesses Llp Corporate entity Shares 25–50%, Voting 25–50% 2016-04-06 Ceased 2018-12-12

Filing timeline

Last 20 of 206 total filings

Date Type Category Description
2025-11-18 CH01 officers Change person director company with change date PDF
2025-11-13 CS01 confirmation-statement Confirmation statement with no updates PDF
2025-09-18 AA accounts Accounts with accounts type full
2025-01-07 PSC05 persons-with-significant-control Change to a person with significant control PDF
2024-11-13 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-11-13 CH01 officers Change person director company with change date PDF
2024-11-13 AD01 address Change registered office address company with date old address new address PDF
2024-11-13 TM02 officers Termination secretary company with name termination date PDF
2024-11-13 AP04 officers Appoint corporate secretary company with name date PDF
2024-10-02 AA accounts Accounts with accounts type full
2023-11-21 CH01 officers Change person director company with change date PDF
2023-11-20 CH01 officers Change person director company with change date PDF
2023-11-20 CH01 officers Change person director company with change date PDF
2023-11-20 CH01 officers Change person director company with change date PDF
2023-11-20 CS01 confirmation-statement Confirmation statement with no updates PDF
2023-11-14 PSC05 persons-with-significant-control Change to a person with significant control PDF
2023-10-19 MR04 mortgage Mortgage satisfy charge full PDF
2023-10-19 MR04 mortgage Mortgage satisfy charge full PDF
2023-10-16 MR01 mortgage Mortgage create with deed with charge number charge creation date PDF
2023-10-16 MR01 mortgage Mortgage create with deed with charge number charge creation date PDF

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
3

last 12 months

Capital events
0

last 24 months

Officers appointed
0

last 12 months

Officers resigned
0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Year-on-year

FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Official Companies House page